Akiri AB

Akiri AB Akiri AB: Science & Patent Information – Retrieval & Analysis

Akiri AB tillhandahåller vetenskaplig information.

Akiri tillhandahåller vetenskaplig information för många olika frågeställningar. Vi har en unik kompetens inom områdena kemi, läkemedel och patent och stöttar kunder med exempelvis nyhetssökningar, freedom-to-operate-sökningar, övergripande sökningar inom ett område eller konkurrentbevakningar. En av våra specialiteter är kemiska struktursökningar. Våra kunder är både små och stora företag och pat

entbyråer. Vi ser fram emot att diskutera dina specifika behov för att genom skräddarsydda och professionella sökningar och analyser ge dig vårt bästa stöd. Akiri is specialised in searching and analysing scientific information. We offer professional support for your patent and literature search requests and support both small and large companies. We have got a unique competence in the areas of chemistry, medical science and patents and support our customers with searches and analyses for questions like novelty, freedom-to-operate, state of the art searches or competitor surveillance. One of our specialities is chemical structure searches. We look forward to discuss your specific needs to tailor-make the searches and analyses to support you in the best way.

Just got my certificate. I am now a Qualified Patent Information Professional (QPIP).Please, visit www.akiri.se for more...
09/05/2019

Just got my certificate. I am now a Qualified Patent Information Professional (QPIP).
Please, visit www.akiri.se for more information on how I can support you.

På väg hem med mycket intressant i bagaget efter intensiva och givande dagar på NLSDays i Stockholm.
12/09/2018

På väg hem med mycket intressant i bagaget efter intensiva och givande dagar på NLSDays i Stockholm.

Congratulations!Senzime, one of my customers, got the CE mark approval for OnZurf Probe. I am pleased to know that my th...
29/12/2017

Congratulations!
Senzime, one of my customers, got the CE mark approval for OnZurf Probe. I am pleased to know that my thorough literature searches and analyses at Akiri AB made one part of the Clinical Evaluation Report, making basis for the approval.
Margareta

Uppsala, December 18, 2017. Senzime AB (publ) announces that the company has received CE mark

I wish you all a Merry Christmas and a Happy New Year!Margareta
23/12/2017

I wish you all a Merry Christmas and a Happy New Year!
Margareta

Ser fram emot givande möten i Malmö.
12/09/2017

Ser fram emot givande möten i Malmö.

How unique is your invention?
Akiri gives you the answer.
Learn more at www.akiri.se.

See you at NLSDays (Nordic Life Science Days) in Malmö 13-14 September this week.
12/09/2017

See you at NLSDays (Nordic Life Science Days) in Malmö 13-14 September this week.

How unique is your invention?
Akiri gives you the answer.
Learn more at www.akiri.se.

How unique is your invention?Akiri gives you the answer.Learn more at www.akiri.se.
29/06/2017

How unique is your invention?
Akiri gives you the answer.
Learn more at www.akiri.se.

20/01/2017
23/12/2016
Good meetings and talks today at Park Annual.
29/09/2016

Good meetings and talks today at Park Annual.

Second and last day at Nordic Life Science Days in Stockholm. Having had many good and interesting meetings - also promi...
15/09/2016

Second and last day at Nordic Life Science Days in Stockholm. Having had many good and interesting meetings - also promising for future collaborations.

13/09/2016

Looking forward to seeing you at Nordic Life Science Days in Stockholm Wednesday-Thursday this week!

The Nordic region is proud to host some of the world’s most innovative biotech, medtech and pharma companies. It also has the 12th strongest economy, making it the perfect place to invest. Set in the idyllic city of Stockholm, the conference offers conference sessions, panel discussions, company pr...

Adress

Högabergsvägen 4
Gothenburg
43640

Webbplats

Aviseringar

Var den första att veta och låt oss skicka ett mail när Akiri AB postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Genvägar

Dela

Typ